Collecting pleural tissue samples to study mesothelioma markers
Part of Cancer clinical trials.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult age 18 or older
- Have malignant pleural mesothelioma (a cancer of the lining around the lung)
- Be getting a diagnostic pleural biopsy, pleuroscopy, and/or VATS surgery as part of care
- Be able to go through the planned procedure to take tissue samples
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
This study is looking at the immune system and genes in mesothelioma tumors. It aims to learn more about how the body reacts to the cancer, which may help in finding better treatments in the future.
This Phase 1/2 study tests the immune medicines durvalumab and tremelimumab, with or without chemotherapy, given before surgery for mesothelioma. It aims to shrink the tumor and improve safety and outcomes so more patients can have their cancer fully removed.
This trial tests if a partial surgery called pleurectomy can help people with a specific type of mesothelioma that cannot be fully removed. You must have already completed at least 6 weeks of chemotherapy or immunotherapy without the cancer growing.
This study collects and analyzes tumor samples from patients with malignant pleural mesothelioma (a cancer of the lung lining caused by asbestos exposure) to better understand the disease and find new treatment approaches. Researchers will examine your tumor at the molecular level to identify patterns that might help predict treatment outcomes.
Hear when a new Mesothelioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.